🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Percutaneous Coronary Intervention

LAAO Versus NOAC in Patients with AF and PCI NCT05353140NA1 site📍 Xi'an Xijing Hospital · Tests: The WATCHMAN/WATCHMAN FLX device, Rivaroxaban + Clopidogre, Aspirin + Clopidogrel Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients NCT07469397n/a1 site📍 Taipei National Taiwan University Hospital · Tests: Direct Inspection, medical records browsing Radial Access Data in Vascular Interventions Registry NCT07614386n/a1 site📍 Mersin Mersin Medicalpark Hastanesi · Tests: Radial and Ulnar Artery Access NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI NCT05638867Phase 41 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Aspirin + Clopidogrel + Rivaroxaban, Aspirin + Clopidogrel Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions NCT07093788NA3 sites📍 Lianyungang📍 Nanjing📍 Yixing Nanjing First Hospital, Nanjing Medical University · Tests: super high-pressure balloon, intravascular lithotripsy (IVL) Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects NCT05264753n/a15 sites📍 Montreal📍 Le Plessis-Robinson📍 Lille Occlutech International AB · Tests: Occlutech® PDA Occluder Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation NCT06695429NA1 site📍 Cartagena Hospital General Universitario Santa Lucia · Tests: Beetroot juice The Switching Antiplatelet-9 (SWAP-9) Study NCT06588595Phase 41 site📍 Jacksonville University of Florida · Tests: Prasugrel/Ticagrelor monotherapy or aspirin plus clopidogrel, Aspirin plus clopidogrel Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers NCT07566091NA1 site📍 Seoul Jung-min Ahn · Tests: Sirolimus-Ascorbic Acid Eluting Stent, Everolimus-Eluting Stent Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial） NCT06863350NA1 site📍 Chengdu Sichuan University · Tests: patent foramen ovale closure Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction NCT04912518NA9 sites📍 Hefei📍 Lanzhou📍 Harbin Harbin Medical University · Tests: Dexmedetomidine (DEX), Placebo (Saline) Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention NCT04899479Phase 41 site📍 Seoul Samsung Medical Center · Tests: SGLT2 inhibitor, Control Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention NCT04977076NA1 site📍 Heerlen Zuyderland Medisch Centrum · Tests: Uninterrupted DOAC use, Interrupted DOAC use SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective NCT06373601NA10 sites📍 Mercogliano📍 Bergamo📍 Brescia Fondazione Evidence per Attività e Ricerche Cardiovascolari… · Tests: sirolimus-eluting balloon (Selution), paclitaxel-eluting balloon (SeQuent Please Neo) Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention NCT06909565Phase 4147 sites📍 Alexander City📍 Birmingham📍 Huntsville Duke University · Tests: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, Normal Saline (Placebo) Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction NCT05828719NA1 site📍 Seoul Samsung Medical Center · Tests: Percutaneous coronary intervention Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction NCT07467213Phase 31 site📍 Seoul Samsung Medical Center · Tests: Zastaprazan, Proton Pump Inhibitors (PPI) Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NCT07149714NA1 site📍 Moscow National Medical Research Center for Cardiology, Ministry o… · Tests: iVAC 2L Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI NCT04695106Phase 41 site📍 Gdansk Medical University of Gdansk · Tests: Ticagrelor, Dabigatran Etexilate, Aspirin, Clopidogrel RIR and the Impact on Clinical Outcomes in Patients Undergoing PCI NCT05131750n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients NCT05923489NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Routine Angiography Follow-up, Routine Clinical Follow-up Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI NCT05786131NA58 sites📍 Graz📍 Innsbruck📍 Vienna Leipzig Heart Science gGmbH · Tests: Culprit-lesion revascularization, Non-culprit-lesion revascularization IRIS-Coroflex NEO Cohort NCT06177743n/a11 sites📍 Seoul📍 Bucheon-si📍 Bucheon-si Seung-Jung Park · Tests: Coroflex ISAR NEO stent LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients NCT06657326NA6 sites📍 Johor Bahru📍 Kuantan📍 Ipoh Biosensors Europe SA · Tests: BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent, BioFreedom™ stainless steel Biolimus A9™-coated stent Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions NCT07316504NA2 sites📍 Clermont-Ferrand📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: Intravascular lithotripsy, Balloon Frailty Syndrome in Daily Practice of Interventional Cardiology Ward NCT03209414n/a1 site📍 Zabrze Medical University of Silesia Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome NCT07773272n/a1 site📍 Heerlen Zuyderland Medisch Centrum · Tests: Rapid ESC-guideline based secondary prevention following myocardial infaction Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention NCT06274411NA1 site📍 Beijing Beijing Anzhen Hospital · Tests: Standby cannulated ECMO, Prophylactic ECMO Effects of Alternate Nostril Breathing Versus Diaphragmatic Breathing on Oxygen Saturation and Heart-rate Variability in Post Percutaneous Coronary Intervention Patients NCT07867457NA1 site📍 Rawalpindi Foundation University Islamabad · Tests: Alternate Nostril Breathing, Diaphragmatic breathing Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. NCT07582835Phase 31 site📍 Lugano Cardiocentro Ticino · Tests: Clopidogrel, Ticagrelor, Prasugrel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy